These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7586929)

  • 21. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine.
    Egnell AC; Houston B; Boyer S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1251-62. PubMed ID: 12606595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of felbamate on selected central effects of ethanol in experimental animals.
    Pietrzak B; Czarnecka E
    Acta Pol Pharm; 2004; 61(3):209-13. PubMed ID: 15481247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential pharmacokinetic interaction between felbamate and phenobarbital.
    Gidal BE; Zupanc ML
    Ann Pharmacother; 1994 Apr; 28(4):455-8. PubMed ID: 8038465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voltage-activated calcium channels: targets of antiepileptic drug therapy?
    Stefani A; Spadoni F; Bernardi G
    Epilepsia; 1997 Sep; 38(9):959-65. PubMed ID: 9579933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices.
    Calabresi P; Siniscalchi A; Pisani A; Stefani A; Mercuri NB; Bernardi G
    Neurology; 1996 Aug; 47(2):557-62. PubMed ID: 8757038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine.
    van Heiningen PN; Eve MD; Oosterhuis B; Jonkman JH; de Bruin H; Hulsman JA; Richens A; Jensen PK
    Clin Pharmacol Ther; 1991 Oct; 50(4):410-9. PubMed ID: 1914377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
    Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V
    Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose pharmacokinetics of felbamate in patients with renal dysfunction.
    Glue P; Sulowicz W; Colucci R; Banfield C; Pai S; Lin C; Affrime MB
    Br J Clin Pharmacol; 1997 Jul; 44(1):91-3. PubMed ID: 9241102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Felbamate overdose: a case report and discussion of a new antiepileptic drug.
    Nagel TR; Schunk JE
    Pediatr Emerg Care; 1995 Dec; 11(6):369-71. PubMed ID: 8751173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
    Andreasen AH; Brøsen K; Damkier P
    Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology and pharmacokinetics of oxcarbazepine.
    Lloyd P; Flesch G; Dieterle W
    Epilepsia; 1994; 35 Suppl 3():S10-3. PubMed ID: 8156973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felbamate increases phenytoin but decreases carbamazepine concentrations.
    Fuerst RH; Graves NM; Leppik IE; Brundage RC; Holmes GB; Remmel RP
    Epilepsia; 1988; 29(4):488-91. PubMed ID: 3391153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxcarbazepine disposition: preliminary observations in patients.
    Kumps A; Wurth C
    Biopharm Drug Dispos; 1990; 11(4):365-70. PubMed ID: 2340349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.